DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20201327

Audit of fresh frozen plasma usage, prospective study: a report from department of immunohematology and transfusion medicine, government medical college Jammu, Jammu and Kashmir, India

Saadat Nazir Shah, Meena Sidhu, Vidushi Gupta

Abstract


Background: Fresh frozen plasma is commonly used in tertiary care hospitals. These are used to manage conditions such as coagulation derangements. Unnecessary use of fresh frozen plasma (FFP) is known to increase the risk of side effects in plasma transfusing patients like anaphylaxis, transfusion related acute lung injury (TRALI) and risk of transfusion transmitted infections etc. So judicious use of plasma is extremely important where its benefits outweigh its potential risks.

Methods: Prospective observational study conducted over a period of six month. The following data were collected; provisional clinical diagnosis, indication of FFP’S, coagulation profile and gender of the patients. We evaluated all FFP transfusions, classified them as appropriate or inappropriate according to fresh frozen plasma transfusion guidelines of Directorate general of health services (DGHS).

Results: A total of 808 FFP units were issued (474 units to males and 334 units to females) over a period of 6 months. Out of these, 15% (122 units) of  FFP’s were issued to intensive care unit (ICU) patients, 12.87% (104 units) to paediatrics ward, 12.25%  (99 units) to emergency ward which include patients with upper GI bleed and lower GI bleed , 6.8% (55 units) to obstetrics patients, 6.18% (50 units) to orthopaedics, 4.45% (36 units)  to road traffic accident patients, 4.20% (34 units) to Hepatic failure patients, 3.09% (25 units) to Cardiothoracic and vascular surgery (CTVS), 2.97% (24 units) to oncology patients, 2.47% (20 units) to snake bite patients, 1.23 % (10 units) to dengue patients, 1.11% (9 units)  to Haemophilia  patients, 27.38% units were issued to the patients were indication for FFP transfusion was not known.

Conclusions: study showed that 66.44% were appropriate and 33.56% were inappropriate use of FFP’s in patients. This highlights the pitfalls in use of FFP among clinicians and for that matter there is need of awareness and understanding the transfusion medicine by clinicians.


Keywords


Audit, Coagulation profile, Fresh frozen plasma, Potential risks

Full Text:

PDF

References


Prinja N, Sharma S, Narain R. Fresh frozen plasma utilization pattern in tertiary care hospital of North Western India. Int J Res Med Sci. 2017;5:5372-5.

O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28.

National Health and Medical Research Council and Australasian Society of Blood Transfusion. Clinical practice guidelines on the use of blood components (red blood cells, platelets, fresh frozen plasma, cryoprecipitate). Canberra: NHMRC and ASBT, 2002; 1-75.

Task Force on Blood Component Therapy. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists. Anesthesiol. 1996;83:732-47.

Bowden R, Sayers M. The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion. 1990;30:762-3.

Wong MP, Droubatchevskaia N, Chipperfield KM, Wadsworth LD, Ferguson DJ. Guidelines for frozen plasma transfusion. BCMJ. 2007;49:311-9.

Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J. 2003;44:574-8.

Kakkar N, Kaur R, Dhanoa T. A prospective audit of transfusion requests in a tertiary hospital. Indian J Haematol Blood Transf. 2003;21:159-60.

Basu S, Marwaha N. Fresh frozen plasma: Indications and patterns of usage. Indian J Haematol Blood Transf. 2001;19:51-2.

Chatterjee M, Bharucha ZS. Retrospective audit of transfusion practice in surgical oncology. Indian J Hematol Blood Transf. 1998;16:107-12.

Eagleton H, Benjamin S, Murphy MF. Audits of appropriate use of FFP. Blood Matters. 2000;4:5-8.

Luk C, Eckert KM, Barr RM, Chin-Yee IH. Prospective audit of the use of fresh-frozen plasma based on Canadian Medical Association transfusion guidelines. CMAJ. 2002;166:1539-40.